Skip to main content
Equibles

Driehaus Capital Management LLC

Position in RZLT — Rezolute, Inc.

CIK 938206 Chicago, IL
Back to RZLT Full portfolio

Position in RZLT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,505,498
-$684,702 QoQ
Shares Held
289,519
+24.3% QoQ
Ownership
0.301%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#41
of 144 holders
Holding Since
Jun 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RZLT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Driehaus Capital Management LLC holds $3,707,249,767 across 60 Biotechnology names. RZLT ranks #57 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DFTX
Definium Therapeutics, Inc.
 6,845,276 $322,001,783
2 PRAX
Praxis Precision Medicines, Inc.
 959,048 $321,079,679
3 XENE
Xenon Pharmaceuticals Inc.
 4,418,557 $266,704,100
4 SYRE
Spyre Therapeutics, Inc.
 2,799,166 $248,509,957
5 CRNX
Crinetics Pharmaceuticals, Inc.
 6,463,551 $241,866,078
6 APGE
Apogee Therapeutics, Inc.
 1,740,101 $230,963,605
7 EWTX
Edgewise Therapeutics, Inc.
 4,728,623 $192,123,952
8 SEPN
Septerna, Inc.
 4,433,058 $148,463,112

All Filings in RZLT

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,505,498 289,519
2025-09-30 $2,190,200 233,000
2025-06-30 $1,039,180 233,000